- Exchange: Stockholm
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Instruments
Snapshot for Elekta AB (EKTAB)
| Open: | 101.600 | Day's Range: | 100.900 - 101.700 | Volume: | 811,881 |
|---|---|---|---|---|---|
| Previous Close: | 101.700 | 52wk Range: | 76.625 - 105.300 | 1-Yr Rtn: | +22.57% |
Key Statistics for EKTAB
| Current P/E Ratio (ttm) | 36.8095 |
|---|---|
| Estimated P/E(04/2013) | 27.7201 |
| Relative P/E vs. OMX | 2.2590 |
| Earnings Per Share (SEK) (ttm) | 2.7547 |
| Est. EPS (SEK) (04/2013) | 3.6580 |
| Est. PEG Ratio | 1.6154 |
| Market Cap (M SEK) | 38,818.36 |
| Shares Outstanding (M) | 368.57 |
| 30 Day Average Volume | 1,115,812 |
| Price/Book (mrq) | 8.1418 |
| Price/Sale (ttm) | 3.9483 |
| Dividend Indicated Gross Yield | 1.23% |
| Cash Dividend (SEK) | 1.2500 |
| Last Dividend | 09/05/2012 |
| 5 Year Dividend Growth | 37.97% |
| Next Earnings Announcement | 06/05/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for EKTAB
Company Profile & Key Executives for EKTAB
Elekta AB produces and sells advanced medical products for treatment of neurological disorders and radiation of cancer. The Company has developed the Gamma Knife, a non-invasive surgical tool for the management of small and hard to locate intracranial lesions, as well as a complete system for stereotactic neurosurgery. Elekta markets worldwide.
| Tomas PuuseppPresident/CEO/Acting VP:EMEA | Hakan BergstromChief Financial Officer |
| Johan SedihnChief Operating Officer | Asa HedinExec VP:Neuroscience |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
EKTAB News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page